The influence of hemodialysis membrane permeability on serum procalcitonin values in patients on maintenance hemodialysis

Abstract

Background:

Procalcitonin (PCT) has emerged as a marker of infection and it could be useful for detection of systemic bacterial infections in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD). The aim of this study was to assess the influence of HD membrane permeability to PCT serum levels in noninfected HD patients on maintenance HD.

Methods:

In a prospective comparative study, we measured PCT serum levels and C reactive protein (CRP) before and after HD in 36 sessions (18 sessions of HD with low-flux = Group L; and 18 sessions with high flux membranes = Group H), in 18 chronic HD patients without history of infection.

Results:

Sessions of HD by high-flux membranes (Group H) displayed median PCT values that were significantly decreased after dialysis (0.21 ng/mL [0.13-0.41] vs. 0.18 ng/mL [0.10-0.24], p <0.001) but median PCT significantly increased after HD sessions by low-flux membranes (Group L) (0.21 ng/mL [0.14-0.33] vs. 0.25 ng/mL [0.14-0.36]; p = 0.008). CRP values were significantly increased after HD in both groups. CRP correlated with PCT values only in group H before HD (r = 0.49; p = 0.36).

Conclusions:

PCT represents a useful diagnostic marker for systemic bacterial infection. However, there is a need for specific reference ranges to be developed in patients with renal failure undergoing HD; also, PCT serum levels must be interpreted according to the HD membrane permeability.

Keywords

C-reactive protein Hemodialysis Membrane Permeability Procalcitonin

Get full access to this article

View all access options for this article.

References

Khan

Catto

GRD

. Long-term complications of dialysis: infection. Kidney Int Suppl. 1993;41:S143–S148.

Herget-Rosenthal

Marggraf

Pietruck

et al . Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant. 2001;16(5):975–979.

Assicot

Gendrel

Carsin

Raymond

Guilbaud

Bohuon

. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518.

Maruna

Nedelníková

Gürlich

. Physiology and genetics of procalcitonin. Physiol Res. 2000;49(Suppl 1):S57–S61.

Le Moullec

Jullienne

Chenais

et al . The complete sequence of human preprocalcitonin. FEBS Lett. 1984;167(1):93–97.

Mori

Noguchi

Sumino

Sato

Mimata

. Use of procalcitonin in patients on chronic hemodialysis: procalcitonin is not related with increased serum calcitonin. ISRN Urology, 2012.

Oberhoffer

Stonans

Russwurm

et al . Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med. 1999;134(1):49–55.

Dandona

Nix

Wilson

et al . Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79(6):1605–1608.

Nylen

Whang

Snider

Jr Steinwald

White

Becker

. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med. 1998;26(6):1001–1006.

10.

Herbelin

Nguyen

Zingraff

Ureña

Descamps-Latscha

. Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha. Kidney Int. 1990;37(1):116–125.

11.

Herbelin

Ureña

Nguyen

Zingraff

Descamps-Latscha

. Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int. 1991;39(5):954–960.

12.

Simon

Gauvin

Amre

Saint-Louis

Lacroix

. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217.

13.

Schmidt

Burchardi

Sitter

Held

Schiffl

. Procalcitonin in patients undergoing chronic hemodialysis. Nephron. 2000;84(2):187–188.

14.

Herget-Rosenthal

Klein

Marggraf

et al . Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol. 2005;61(2):180–186.

15.

Meisner

Lohs

Huettemann

Schmidt

Hueller

Reinhart

. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol. 2001;18(2):79–87.

16.

Whicher

Bienvenu

Monneret

. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38(5):483–493.

17.

Pereira

Shapiro

King

Falagas

Strom

Dinarello

. Plasma levels of IL-1 beta, TNF α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 1994;45(3):890–896.

18.

Montagnana

Lippi

Tessitore

et al . Procalcitonin values after dialysis is closely related to type of dialysis membrane. Scand J Clin Lab Invest. 2009;69(6):703–707.

19.

Owen

Lowrie

. C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int. 1998;54(2):627–636.

20.

Zimmermann

Herrlinger

Pruy

Metzger

Wanner

. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999;55(2):648–658.

21.

Prat

Sancho

Dominguez

et al . Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma. 2008;49(9):1752–1761.

22.

Conti

Amore

Chiesa

et al . Procalcitonin as a marker of micro-inflammation in hemodialysis. J Nephrol. 2005;18(3):282–288.

23.

Herget-Rosenthal

Marggraf

Pietruck

et al . Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant. 2001;16(5):975–979.

24.

Galli

. Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant. 2007;22(Suppl 5):v20–v36.

25.

Ooi

House

. Cardiac troponin T in hemodialyzed patients. Clin Chem. 1998;44(7):1410–1416.

26.

Dahaba

Elawady

Rehak

List

. Procalcitonin and proinflammatory cytokine clearance during continuous venovenous haemofiltration in septic patients. Anaesth Intensive Care. 2002;30(3):269–274.

27.

Meisner

Hüttemann

Lohs

Kasakov

Reinhart

. Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock. 2001;15(3):171–175.

28.

Meisner

Hüttemann

Lohs

Kasakov

Reinhart

. Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol. 2000;17(11):665–671.